| Ident. | Authors (with country if any) | Title |
|---|
| 000094 |
Beatrice Brembilla-Perrot [France] ; Rouzbeh Valizadeh Moejezi [France] ; Pierre Yves Zinzius [France] ; Soumaya Jarmouni [France] ; Jérôme Schwartz [France] ; Daniel Beurrier [France] ; Jean Marc Sellal [France] ; Ibrahim Nossier [France] ; Lucian Muresan [France] ; Marius Andronache [France] ; Radou Moisei [France] ; Olivier Selton [France] ; Pierre Louis [France] ; Arnaud Terrier De La Chaise [France] | Missing diagnosis of preexcitation syndrome on ECG Clinical and electrophysiological significance |
| 000197 |
Maria C. Rodriguez-Oroz [Espagne] ; Elena Moro [Canada] ; Paul Krack [France] | Long-Term Outcomes of Surgical Therapies for Parkinson's Disease |
| 000219 |
Elaine M. Dennison [Royaume-Uni, Nouvelle-Zélande] ; Juliet E. Compston [Royaume-Uni] ; Julie Flahive [États-Unis] ; Ethel S. Siris [États-Unis] ; Stephen H. Gehlbach [États-Unis] ; Jonathan D. Adachi [Canada] ; Steven Boonen [Belgique] ; Roland Chapurlat [France] ; Adolfo Diez-Perez [Espagne] ; Frederick A. Jr Anderson [États-Unis] ; Frederick H. Hooven [États-Unis] ; Andrea Z. Lacroix [États-Unis] ; Robert Lindsay [États-Unis] ; J. Coen Netelenbos [Pays-Bas] ; Johannes Pfeilschifter [Allemagne] ; Maurizio Rossini [Italie] ; Christian Roux [France] ; Kenneth G. Saag [États-Unis] ; Philip Sambrook [Australie] ; Stuart Silverman [États-Unis] ; Nelson B. Watts [États-Unis] ; Susan L. Greenspan [États-Unis] ; Melissa Premaor ; Cyrus Cooper [Royaume-Uni] | Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW) |
| 000322 |
Solène Genty [France] ; Stephane Derrey [France] ; Sophie Pouplin [France] ; Romain Lefaucheur [France] ; Nathalie Chastan [France] ; Emmanuel Gerardin [France] ; David Maltete [France] | Pain due to osteoarthritis may impair the early outcome of deep brain stimulation in Parkinson's disease |
| 000337 |
Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Oliver Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni] | Health-Related Quality-of-Life Scales in Parkinson's Disease: Critique and Recommendations |
| 000471 |
Tiphaine Rouaud [France] ; Thibaut Dondaine [France] ; Sophie Drapier [France] ; Claire Haegelen [France] ; François Lallement [France] ; Julie Peron [France] ; Sylvie Raoul [France] ; Paul Sauleau [France] ; Marc Verin [France] | Pallidal Stimulation in Advanced Parkinson's Patients with Contraindications for Subthalamic Stimulation |
| 000511 |
Richard G. Brown [Royaume-Uni] ; Lucette Lacomblez [France] ; Bernard G. Landwehrmeyer [Allemagne] ; Thomas Bak [Royaume-Uni] ; Ingo Uttner [Allemagne] ; Bruno Dubois [France] ; Yves Agid [France] ; Albert Ludolph [Allemagne] ; Gilbert Bensimon [France] ; Christine Payan [France] ; Nigel P. Leigh [Royaume-Uni] | Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy |
| 000585 |
Clemence Simonin [France] ; M. Tir [France] ; D. Devos [France] ; A. Kreisler [France] ; K. Dujardin [France] ; J. Salleron [France] ; A. Delval [France] ; S. Blond [France] ; L. Defebvre [France] ; A. Destee [France] ; P. Krystkowiak [France] | Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon |
| 000767 |
Jean-Marc Trocello [France] ; Paolo Zanotti-Fregonara [France] ; Emmanuel Roze [France] ; Emmanuelle Apartis [France] ; André-Pierre Legrand [France] ; Marie-Odile Habert [France] ; Jean-Yves Devaux [France] ; Marie Vidailhet [France] | Dopaminergic Deficit Is Not the Rule in Orthostatic Tremor |
| 000796 |
Valerie Voon [États-Unis, Canada] ; Paul Krack [France] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; Kathy Dujardin [France] ; Michael Schüpbach [France] ; James D'Ambrosia [États-Unis] ; Stephane Thobois [France] ; Filippo Tamma [Italie] ; Jan Herzog [Allemagne] ; Johannes D. Speelman [Pays-Bas] ; Johan Samanta [États-Unis] ; Cynthia Kubu [États-Unis] ; Helene Rossignol [France] ; Yu-Yan Poon [Canada] ; Jean A. Saint-Cyr [Canada] ; Claire Ardouin [France] ; Elena Moro [Canada] | A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease |
| 000899 |
Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Marion Simonetta-Moreau [France] ; Nelly Fabre [France] ; Jean Albert Lotterie [France] ; Patrick Chaynes [France] ; Isabelle Berry [France] ; Yves Lazorthes [France] ; Olivier Rascol [France] | Does ageing influence deep brain stimulation outcomes in Parkinson's disease? |
| 000916 |
Dominique Saragaglia [Royaume-Uni] ; Frédéric Picard [Royaume-Uni] ; Francois Leitner [France] | An 8-to 10-year follow-up of 26 computer-assisted total knee arthroplasties |
| 000B53 |
Dominique Caparros-Lefebvre [France] ; Andrew J. Lees [Royaume-Uni] | Atypical unclassifiable parkinsonism on guadeloupe : An environmental toxic hypothesis |
| 000B85 |
D. Crepin [France] ; M. Jimenez [France] ; J. B. Thambo [France] ; R. Girardot [France] ; A. Choussat [France] | Facteurs prédictifs de mortalité dans la maladie d'Ebstein |
| 000D40 |
Jean-Luc Houeto [France] ; Marie-Laure Welter [France] ; Paul-Boulos Bejjani [Liban] ; Sophie Tezenas Du Montcel [France] ; Anne-Marie Bonnet [France] ; Valerie Mesnage [France] ; Soledad Navarro [France] ; Bernard Pidoux [France] ; Didier Dormont [France] ; Philippe Cornu [France] ; Yves Agid [France] | Subthalamic stimulation in Parkinson disease: Intraoperative predictive factors |
| 000D42 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias [Canada] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study |
| 000D52 |
Bechir Jarraya [France] ; Anne-Marie Bonnet [France] ; Charles Duyckaerts [France] ; Jean-Luc Houetc [France] ; Philippe Cornu [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] | Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathologic study |
| 000E02 |
Béatrice Brembilla-Perrot [France] ; Hielko Miljoen [France] ; Pierre Houriez [France] ; Daniel Beurrier [France] ; Marc Nippert [France] ; Anne Claire Vancon [France] ; Arnaud Terrier De La Chaise [France] ; Pierre Louis [France] ; Laurent Mock [France] ; Nicolas Sadoul [France] ; Marius Andronache [France] | Causes and prognosis of cardiac arrest in a population admitted to a general hospital; a diagnostic and therapeutic problem |
| 000E44 |
P. Krack [France] | Maladie de Parkinson : stimulation cérébrale profonde |
| 000E62 |
P. Cesaro [France] | Greffes neuronales et maladie de Parkinson |
| 000E78 |
E. Moro [France, Italie] ; R. J. A. Esselink [France, Pays-Bas] ; J. Xie [France] ; M. Hommel [France] ; A. L. Benabid [France] ; P. Pollak [France] | The impact on Parkinson's disease of electrical parameter settings in STN stimulation |
| 000E90 |
J. Vesper [Allemagne] ; F. Klostermann [Allemagne] ; F. Stockhammer [Allemagne] ; Th. Funk [Allemagne] ; M. Brock [Allemagne] ; A. L. Benabid [France] ; Ali Savas [Turquie] ; Cenk Akbostanci [Turquie] ; Yücel Kanpolat [Turquie] | Results of chronic subthalamic nucleus stimulation for Parkinson's disease: A 1-year follow-up study. Commentary |
| 000E99 |
P. D. Charles [France, États-Unis] ; N. Van Blercom [France] ; P. Krack [France] ; S. L. Lee [États-Unis] ; J. Xie [France] ; G. Besson [France] ; A.-L. Benabid [France] ; P. Pollak [France] | Predictors of effective bilateral subthalamic nucleus stimulation for PD |
| 000F12 |
Maria C. Obinu [France] ; Michel Reibaud [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Assunta Imperato [France] | Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence |
| 000F25 |
Franck Durif [France] ; Jean-Jacques Lemaire [France] ; Bérengère Debilly [France] ; Gérard Dordain [France] | Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's Disease |
| 000F35 |
Luc J. P. Defebvre [France] ; Pierre Krystkowiak [France] ; Jean-Louis Blatt [France] ; Alain Duhamel [France] ; Jean-Louis Bourriez [France] ; Myriame Perina [France] ; Serge Blond [France] ; Jean-Daniel Guieu [France] ; Alain Destée [France] | Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease |
| 000F47 |
J. Vesper [Allemagne] ; S. Chabardes [France] ; V. Fraix [France] ; N. Sunde [Danemark] ; K. Stergaard [Danemark] | Dual channel deep brain stimulation system (Kinetra) for Parkinson's disease and essential tremor: a prospective multicentre open label clinical study |
| 000F58 |
Luc Mallet [France] ; Valérie Mesnage [France] ; Jean-Luc Houeto [France] ; Antoine Pelissolo [France] ; Jérome Yelnik [France] ; Cécile Behar [France] ; Marcella Gargiulo [France] ; Marie-Laure Welter [France] ; Anne-Marie Bonnet [France] ; Bernard Pillon [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Bernard Pidoux [France] ; Jean-Francois Allilaire [France] ; Yves Agid [France] | Compulsions, Parkinson's disease, and stimulation |
| 000F61 |
M. L. Welter [France] ; J. L. Houeto [France] ; S. Tezenas Du Montcel [France] ; V. Mesnage [France] ; A. M. Bonnet [France] ; B. Pillon [France] ; I. Arnulf [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France] | Clinical predictive factors of subthalamic stimulation in Parkinson's disease |
| 001072 |
V. Fraix [France] ; P. Pollak ; N. Van Blercom ; J. Xie ; P. Krack [Allemagne] ; A. Koudsie ; A. L. Benabid | Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease |
| 001078 |
S. Descombes [France] ; A. M. Bonnet [France] ; U. E. Gasser [Suisse] ; C. Thalamas [France] ; J. Dingemanse [Suisse] ; I. Arnulf [France] ; M. P. Bareille [France] ; Yves Agid [France] ; O. Rascol [France] | Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease |
| 001088 |
Sylvain M. Chauvaud [France] ; Gianluca Brancaccio [France] ; Alain F. Carpentier [France] | Cardiac arrhythmia in patients undergoing surgical repair of Ebstein's anomaly |
| 001183 |
K. Berger [Allemagne] ; M. M. B. Breteler [Pays-Bas] ; C. Helmer [France] ; D. Inzitari [Italie] ; L. Fratiglioni [Suède] ; C. Trenkwalder [Allemagne] ; A. Hofman [Pays-Bas] ; L. J. Launer [Pays-Bas, États-Unis] | Prognosis with Parkinson's disease in Europe : A collaborative study of population-based cohorts |
| 001338 |
P. Chevalier [France] ; L. Bontemps [France] ; M. Fatemi [France] ; S. Velon [France] ; E. Bonnefoy [France] ; G. Kirkorian [France] ; R. Itti [France] ; P. Touboul [France] | Gated blood-pool SPECT evaluation of changes after radiofrequency catheter ablation of accessory pathways evidence for persistent ventricular preexcitation despite successful therapy |
| 001339 |
P. Krack [France, Allemagne] ; P. Pollak [France] ; P. Limousin [France, Royaume-Uni] ; A. Benazzouz [France] ; G. Deuschl [Allemagne] ; A.-L. Benabid [France] | From off-period dystonia to peak-dose chorea : The clinical spectrum of varying subthalamic nucleus activity |
| 001366 |
F. Durif [France] ; J.-J. Lemaire [France] ; B. Debilly [France] ; G. Dordain [France] | Acute and chronic effects of anteromedial globus pallidus stimulation in Parkinson's disease |
| 001438 |
A. L. Benabid [France] ; A. Benazzouz [France] ; D. Hoffmann [France] ; P. Limousin [France] ; P. Krack [France] ; P. Pollak [France] | Long-term electrical inhibition of deep brain targets in movement disorders |
| 001498 |
N. Fabre [France] ; C. Brefel-Courbon [France] ; O. Rascol [France] | Parkinson « plus » : Mouvements anormaux |
| 001577 |
O. L. Lopez [États-Unis] ; S. R. Wisnieski [États-Unis] ; J. T. Becker [États-Unis] ; F. Boller [France] ; S. T. Dekosky [États-Unis] | Extrapyramidal signs in patients with probable Alzheimer disease |
| 001620 |
A.-M. Bonnet [France] | La maladie de Parkinson : Etat de la question : Sciences médicales |
| 001645 |
G.-L. Defer [France] ; C. Geny [France] ; F. Ricolfi [France] ; G. Fenelon [France] ; J.-C. Monfort [France] ; P. Remy [France] ; G. Villafane [France] ; R. Jeny [France] ; Y. Samson [France] ; Y. Keravel [France] ; A. Gaston [France] ; J.-D. Degos [France] ; M. Peschanski [France] ; P. Cesaro [France] ; J.-P. Nguyen [France] | Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach |
| 001932 |
D. Caparros-Lefebvre [France] ; S. Blond [France] ; N. Pecheux ; F. Pasquier ; H. Petit | Evaluation neuropsychologique avant et après stimulation thalamique chez 9 parkinsoniens |
| 001960 |
S. Blond [France] ; D. Caparros-Lefevre ; F. Parker ; R. Assaker ; H. Petit ; J.-D. Guieu ; J.-L. Christiaens | Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus |
| 001966 |
J. Ventre [France] ; D. S. Zee ; H. Papageorgiou ; S. Reich | Abnormalities of predictive saccades in hemi-Parkinson's disease |
| 001971 |
B. Brembilla-Perrot [France] ; P. Hanrion | Valeur diagnostique de l'épreuve d'effort dans le syndrome de Wolff Parkinson White |
| 001976 |
P. Montgermont [France] ; A. Vacheron | Sport et syndrome de Wolff-Parkinson-White |
| 001B07 |
J. Becquart ; G. Vaksmann ; V. Becquart ; C. Dupuis | Pronostic du syndrome de Wolff-Parkinson-White chez le nourrisson: à propos de 31 observations |
| 001B15 |
M. Ziegler | L'évolution du parkinsonien traité |
| 001B48 |
B. Brembilla-Perrot ; E. Aliot ; P. Louis ; A. Terrier De La Chaise ; K. Khalife ; F. Marcon ; F. Cherrier ; J. M. Gilgenkrantz ; C. Pernot | Devenir de 195 patients atteints de syndrome de Wolff-Parkinson-White |
| 001B74 |
A. Guillard ; C. Chastang ; G. Fenelon | Etude à long terme de 416 cas de maladie de Parkinson. Facteurs de pronostic et implications thérapeutiques |
